Transient Outward Potassium Channel: a Heart Failure Mediator
Overview
Authors
Affiliations
Transient outward K(+) current (Ito) plays a crucial role in shaping the early phase of repolarization and setting the plateau voltage level of action potential. As a result, it extensively affects membrane current flow in the plateau window. A great body of evidence illustrates a transmural gradient of I to within ventricular wall with much higher density in epicardial than endocardial myocytes, which is important for the physiological ventricular repolarization. In heart failure (HF), this gradient is diminished due to a greater reduction of I to in epicardial myocytes. This attenuates the transmural gradient of early repolarization, facilitating conduction of abnormal impulses originated in the epicardium. In addition, I to reduction prolongs action potential duration and increases intercellular Ca(2+), thus affecting Ca(2+) handling and the excitation-contraction coupling. Furthermore, increased intercellular Ca(2+) could activate CaMKII and calcineurin whose role in cardiac hypertrophy and HF development has been well established. Based on the impact of I to reduction on electrical activity, signal conduction, calcium handling and cardiac function, restoration of I to is likely a potential therapeutic strategy for HF. In this review, we summarize the physiological and pathological role of cardiac I to channel and the potential impact of I to restoration on HF therapy with an emphasis of recent novel findings.
Mechanistic Relevance of Ventricular Arrhythmias in Heart Failure with Preserved Ejection Fraction.
Bahrami P, Aromolaran K, Aromolaran A Int J Mol Sci. 2025; 25(24.
PMID: 39769189 PMC: 11677834. DOI: 10.3390/ijms252413423.
Advancing 3D Engineered In Vitro Models for Heart Failure Research: Key Features and Considerations.
van Doorn E, Amesz J, Manintveld O, de Groot N, Essers J, Shin S Bioengineering (Basel). 2025; 11(12.
PMID: 39768038 PMC: 11673263. DOI: 10.3390/bioengineering11121220.
The Cardiomyocyte in Cirrhosis: Pathogenic Mechanisms Underlying Cirrhotic Cardiomyopathy.
Ryu D, Yu F, Yoon K, Liu H, Lee S Rev Cardiovasc Med. 2025; 25(12):457.
PMID: 39742234 PMC: 11683693. DOI: 10.31083/j.rcm2512457.
The Kv4 potassium channel modulator NS5806 attenuates cardiac hypertrophy in vivo and in vitro.
Cai Y, Zhang J, Zhang H, Qi J, Shi C, Xu Y Sci Rep. 2024; 14(1):19839.
PMID: 39191928 PMC: 11349892. DOI: 10.1038/s41598-024-70962-x.
An X, Cho H Sci Rep. 2023; 13(1):22479.
PMID: 38110503 PMC: 10728207. DOI: 10.1038/s41598-023-50088-2.